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An outbreak of febrile illness occurred in Gabon in 2007, 
with 20,000 suspected cases. Chikungunya or dengue-2 vi-
rus infections were identiﬁ  ed in 321 patients; 8 patients had 
documented co-infections. Aedes albopictus was identiﬁ  ed 
as the principal vector for the transmission of both viruses. 
I
n the past 20 years, dengue virus (DENV) and chikungu-
nya virus (CHIKV) have caused large and geographical-
ly wide ranging epidemics (1,2). Recent CHIKV outbreaks 
caused several million clinical cases in the Indian Ocean 
Islands and India (3). The virus has also dispersed to new 
regions, including Gabon in Africa and Italy (4,5). DENVs 
cause the most notable mosquito-borne viral disease in the 
world; ≈100 million infections occur annually worldwide, 
and the incidence has increased >30-fold in the past 50 years 
(1). Despite this tremendous expansion of both diseases, 
relatively few cases of Chikungunya fever have been re-
ported in Africa (3,6,7), and few dengue-2 virus (DENV-2) 
epidemics have been reported (8,9). Simultaneous CHIKV 
and DENV-2 outbreaks have rarely been observed.
CHIKV and DENV-2 are frequently transmitted to 
humans by peridomestic Aedes mosquitoes. Ae. aegypti 
has been considered to be the principal vector in the urban 
transmission cycle, with Ae. albopictus and other anthro-
pophilic Aedes spp. serving as secondary vectors (10,11). 
However, the actual situation is much more complex. First, 
Ae. albopictus was repeatedly shown to be a highly com-
petent vector of CHIKV during the recent outbreaks in the 
Indian Ocean and Italy (5,12). Second, the overall distribu-
tion of Aedes mosquitoes is rapidly changing. Speciﬁ  cally, 
Ae. albopictus (the Asian tiger mosquito) has dispersed 
globally into new territories previously occupied by Ae. ae-
gypti. As a consequence, the characteristics of DENV and 
CHIKV circulation and their outbreak dynamics are likely 
to be modiﬁ  ed.
The Study
We report an arboviral outbreak that occurred in Ga-
bon, Central Africa, from March through July 2007, which 
showed the unexpected extent of the spread of Ae. albopictus 
populations in peridomestic urban areas. We also describe 
its association with atypical epidemiologic characteristics 
such as the co-circulation of CHIKV and DENV-2 and the 
frequency of human co-infections. The outbreak centered 
on the capital of Gabon; peaked from April through May 
2007, in the heat of the long wet season; and subsequently 
moved north, where the virus sequentially reached several 
small towns along the route to northern Gabon and Cam-
eroon (Figure 1). The outbreak generated ≈20,000 cases. 
Patients with suspected cases exhibited a dengue-like syn-
drome, including fever, arthralgia, and asthenia. Conjuncti-
val hemorrhage, maculopapular rash, headache, and vomit-
ing were also observed in the most severe cases.
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Figure 1. Chikungunya and dengue outbreaks in Gabon, 2007. 
Distribution of the outbreak and location of the 7 towns where 
suspected cases were laboratory conﬁ  rmed by using quantitative 
reverse transcription–PCR assay are shown. Chikungunya cases 
are represented by red circles, dengue cases by blue circles, and 
cases negative for both viruses by black circles. Testing methods 
are described in the footnote to the Table.During the course of the outbreak, 773 early blood 
samples (i.e., obtained during the ﬁ  rst week after the on-
set of the disease) were collected from febrile patients who 
visited identiﬁ  ed medical health centers in Libreville and 
other towns in Gabon (Table). Samples were tested for 
the presence of various arboviral RNA genomes by using 
the TaqMan quantitative reverse transcription–PCR (qRT-
PCR) technology and speciﬁ  c primers and probes (proto-
cols available upon request to the corresponding author). 
Among these 773 patients, 275 and 54 were positive for 
CHIKV and DENV, respectively, during May and July 
2007 (Table), with 8 cases of co-infections. Using a den-
gue serotype-speciﬁ  c qRT-PCR assay, we showed that all 
DENV patients were positive for serotype 2 (DENV-2). 
In all 7 towns investigated on the route from Libreville to 
Cameroon (530 km), both CHIKV and DENV-2 human 
cases were reported, except in Cocobeach where only labo-
ratory DENV-2 conﬁ  rmed cases were observed (Figure 1). 
To investigate this atypical scenario further, we analyzed 
4,807 mosquitoes belonging to various species of Aedes 
(2,504 Ae. albopictus, 1,035 Ae. aegypti, 57 Aedes sympso-
ni), Culex (843 Cx. quinquefasciatus, 47 Cx. sp.), Anoph-
eles (78 An. gambiae) and Mansonia (120 M. africana, 123 
M. uniformis) in 15 different locations in Libreville where 
CHIKV or DENV-2 laboratory conﬁ  rmed human cases were 
detected. Pools of 20 mosquitoes (constituted according to 
species and place of collection) were homogenized by us-
ing GenoGrinder 2000 (OPS Diagnostics, Bridgewater, NJ, 
USA) technology, and then tested for CHIKV and DENV-2 
by qRT-PCR. We found that 7 and 3 groups of Ae. albopic-
tus were positive for CHIKV and DENV-2, respectively, 
while no group containing other mosquito species was posi-
tive, indicating that Ae. albopictus was the only or at least the 
prominent vector of the 2 viruses.
These data provide evidence for the presence of CHIKV 
and DENV in Gabon and for their transmission to humans 
by Ae. albopictus. These epidemiologic results also conﬁ  rm 
our previous observation that CHIKV strains isolated during 
the Gabon outbreak in 2007 belong to the Central African 
lineage and harbor the A226V mutation as a result of adapta-
tion to Ae. albopictus through a mechanism of evolutionary 
convergence (4). More surprisingly, our results show that 
the spread of this mosquito in an area previously occupied 
predominantly by Ae. aegypti (13) was accompanied by the 
simultaneous emergence and transmission of DENV-2. One 
DENV-2 strain (designated as Libreville 2007), isolated 
from 1 febrile patient by using E6 Vero cells was further 
characterized by full-length genome sequencing (10,695 nt). 
Phylogenetic analysis showed that the DENV-2 Gabon 2007 
strain belongs to the cosmopolitan, rather than the sylvatic, 
genotype (Figure 2). This cosmopolitan genotype includes 
mainly Asian but also related strains isolated in India, Aus-
tralia, Mexico, the Indian Ocean, and Africa (Uganda, So-
malia, and Burkina Faso), presumably the result of travel to 
these remote locations by viremic patients or the transporta-
tion of commercial goods by ship.
Conclusions
Taken together, these ﬁ  ndings document CHIKV and 
DENV-2 co-circulation that resulted in large simultaneous 
outbreaks in regions where Ae. albopictus was shown to be 
the principal vector. Notably, we identiﬁ  ed 8 patients with 
blood samples that tested positive for the presence of both 
CHIKV and DENV-2 genomes, indicating co-infection of 
these patients by both viruses. However, while unlikely, 
genetic exchanges between the 2 viruses, either by recom-
bination or complementation, are not deﬁ  nitively excluded. 
Clinical examination of these patients (all adults, 5 women 
and 3 men) did not identify speciﬁ  c or severe symptoms, 
although given the limited number of cases and clinical and 
biologic investigations, this observation should be inter-
preted with caution.
Although the DENV cases were few, 8 of 48 (≈17%) 
DENV-2 positive patients from towns affected by the 2 
outbreaks tested positive for CHIKV (Table). Extrapola-
tion of this result suggests that the total number of DENV-2 
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Table. Positive test results for CHIKV and DENV-2 among febrile patients, by town, Gabon, 2007*† 
Towns  No. patients tested  No. CHIKV+  No. DENV-2+  No. CHIKV+/DENV-2+ 
Libreville 686 249 45 6
Ntoum 3 1 0 0
Kango 7 3 0 0
Mitzic 6 4 0 0
Oyem 45 15 2 1
Minvoul 7 3 1 1
Cocobeach 19 0 6 0
Total 773 275 54 8
*CHIKV, chikungunya virus; DENV-2, dengue-2 virus; +, positive. 
†RNA was extracted from 50 μL of plasma by using the ABI Prism 6100 Nucleic Acid PrepStation according to the manufacturer’s recommended
procedures (Applied Biosystems, Foster City, CA, USA). Fifty-microliter aliquots of extracted RNA were then used in 100-μL High Capacity cDNA 
synthesis reactions according to the manufacturer’s instructions (Applied Biosystems). Finally, 10 μL of each cDNA reaction was then used as template 
for 50-μL quantitative PCRs that contained 200 nmol/L of probe and 900 nmol/L of each primer. The quantitative PCRs were then thermo-cycled in a 7500 
Real-Time PCR system (Applied Biosystems) according to manufacturer’s recommended procedures. The probe used for the CHIKV, DENV, and DENV-
2 assays were FAM-labeled with TAMRA quencher (Applied Biosystems).  Concurrent Chikungunya and Dengue Infections
patients who are superinfected with CHIKV is likely to be 
high, which suggests that DENV-2 infection is not the an-
tagonist for a secondary CHIKV infection. In contrast, only 
≈3% of CHIKV+ patients were also DENV-2+; however, 
the starting period of time of infection or the sequence of 
infection by the 2 viruses cannot be assessed.
Although concurrent infections of dengue and chikun-
gunya have been reported (14), such DENV-2 and CHIKV 
co-infections have never been previously associated with 
transmission by Ae. albopictus. Our study therefore pro-
vides a disconcerting example of the unexpected epide-
miologic patterns that may be associated with the disper-
sal of both vectors (Ae. albopictus and Ae. aegypti) and 
pathogenic arboviruses (such as DENV and CHIKV). Ae. 
albopictus mosquitoes are now present in several temper-
ate countries of the Northern Hemisphere where, given the 
opportunity, they could cause future arboviral epidemics. 
The recent sustained indigenous transmission of CHIKV 
by Ae. albopictus in northern Italy (5) provides a potential 
warning of what might occur much more frequently in the 
future in Europe and even in North America. Introduction 
of DENV or CHIKV in these regions are likely to generate 
indigenous transmission by Ae. albopictus.
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Figure 2. Phylogenetic relationships among dengue-2 virus 
(DENV-2) isolates based on full-length sequences (10,695 nt). A 
total of 85 DENV-2 genomes were compared with the human isolate 
obtained during the Gabon outbreak. Phylogeny was inferred 
by using neighbor-joining analysis. A neighbor-joining tree was 
constructed by using MEGA version 3.2 (www.megasoftware.net) 
with the Kimura 2-parameter corrections of multiple substitutions. 
Reliability of nodes was assessed by bootstrap resampling with 
1,000 replicates. Branches are scaled according the number of 
substitutions per site, and the branch leading to the Thailand 94 
strain was shortened for convenience. Bootstrap values are shown 
for major key nodes.